U026 The Birthmark Checklist: A How-To Approach to Evaluating and Managing Childhood Birthmarks
DESCRIPTION
The evaluation of childhood birthmarks is a core skill for any dermatologist caring for children. Over the past decade, advanced genomics has reframed our understanding of birthmarks and their associated syndromes. Hear from leading thinkers in the field as they simplify their approach to childhood birthmarks (congenital melanocytic nevi, vascular malformations, infantile hemangiomas) into a heuristic that's both cutting edge and actionable.
LEARNING OBJECTIVES
Develop a checklist for core birthmarks and birthmark syndromes encountered in practice including next steps in evaluating syndromic features, integrating genomic studies, and essentials in care management
Recognize how advances in tissue sequencing are reframing not just our understanding of birthmarks and mosaic disorders but also informing a new era in targeted treatment.
Identify core principles in the procedural management of childhood birthmarks including both patient and treatment selection
DIRECTOR
Vikash Sudhir Oza, MD, FAAD
SPEAKERS
Elena B. Hawryluk, MD, PhD, FAAD
Anna Yasmine Kirkorian, MD, FAAD
DISCLOSURES
Elena B. Hawryluk, MD, PhD, FAAD
Apogee Therapeutics – Advisory Board(Honoraria); UpToDate, Inc – Other(Other Financial Benefit);
Anna Yasmine Kirkorian, MD, FAAD
Dermavant Sciences, Inc. – Advisory Board(Honoraria); Ebix Inc. – Other(Fees); Incyte – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Fees); Regeneron – Other(Grants/Research Funding); Verrica Pharmaceuticals Inc – Advisory Board(Fees);
Vikash Sudhir Oza, MD, FAAD
Apogee BioPharm – Consultant(Honoraria); Eli Lilly – Advisory Board(Honoraria), Speaker/Faculty Education(Honoraria); Incyte – Advisory Board(Honoraria); National Eczema Association – Advisory Board(Honoraria); Pelthos Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);